Covid-19 vaccines and new mutant strains impacting the pandemic.
作者信息
Matta Shanker, Rajpal Sanjay, Chopra K K, Arora V K
机构信息
New Delhi Tuberculosis Centre, India.
TB Association of India, India.
出版信息
Indian J Tuberc. 2021 Apr;68(2):171-173. doi: 10.1016/j.ijtb.2021.03.010.
Abstract
摘要
相似文献
1
Covid-19 vaccines and new mutant strains impacting the pandemic.新冠疫苗与影响疫情的新突变株。
Indian J Tuberc. 2021 Apr;68(2):171-173. doi: 10.1016/j.ijtb.2021.03.010.
2
Looking beyond COVID-19 as a pandemic.将新冠疫情视为大流行病之外的情况。
Hong Kong Med J. 2021 Apr;27(2):88-89. doi: 10.12809/hkmj215114. Epub 2021 Apr 12.
3
Can COVID-19 vaccines stop the pandemic?新冠疫苗能阻止疫情大流行吗？
Hong Kong Med J. 2021 Apr;27(2):84-85. doi: 10.12809/hkmj215116.
4
Vaccine hesitancy and COVID-19 vaccination in Hong Kong.香港的疫苗犹豫与新冠疫苗接种情况
Hong Kong Med J. 2021 Apr;27(2):90-91. doi: 10.12809/hkmj215115.
5
COVID vaccine makers brace for a variant worse than Delta.新冠疫苗制造商为应对比德尔塔毒株更糟糕的变异毒株做准备。
Nature. 2021 Oct;598(7882):552-553. doi: 10.1038/d41586-021-02854-3.
6
Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.建模澳大利亚针对 SARS-CoV-2 Delta 变异株的疫苗接种对直接和群体保护的效果。
Med J Aust. 2021 Nov 1;215(9):427-432. doi: 10.5694/mja2.51263. Epub 2021 Oct 11.
7
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question.肝病患者的新冠病毒疫苗接种：应对下一个重大问题。
Lancet Gastroenterol Hepatol. 2021 Mar;6(3):156-158. doi: 10.1016/S2468-1253(21)00008-X. Epub 2021 Jan 11.
8
COVID-19 vaccines: what happened to evidence-based medicine?COVID-19 疫苗：循证医学怎么了？
Br J Hosp Med (Lond). 2021 Feb 2;82(2):1-4. doi: 10.12968/hmed.2021.0047. Epub 2021 Feb 3.
9
Covid mutations: honest approach needed from politicians and scientists on pandemic outlook.新冠病毒变异：政治家和科学家需以坦诚态度面对疫情前景
BMJ. 2021 Mar 9;372:n656. doi: 10.1136/bmj.n656.
10
Equitable global access to coronavirus disease 2019 vaccines.2019冠状病毒病疫苗在全球的公平可及性。
BMJ. 2020 Dec 15;371:m4735. doi: 10.1136/bmj.m4735.
引用本文的文献
1
Regulation of innate and adaptive immunity using herbal medicine: benefits for the COVID-19 vaccination.使用草药调节先天性和适应性免疫：对新冠疫苗接种的益处。
Acupunct Herb Med. 2022 Sep;2(3):196-206. doi: 10.1097/HM9.0000000000000046. Epub 2022 Dec 8.
2
Eliciting Opinions on Health Messaging During the COVID-19 Pandemic: Qualitative Survey Study.在新冠疫情期间征集关于健康信息的意见：定性调查研究
JMIR Hum Factors. 2023 Apr 27;10:e39697. doi: 10.2196/39697.
3
Surveillance and Molecular Characterization of SARS-CoV-2 Infection in Non-Human Hosts in Gujarat, India.印度古吉拉特邦非人类宿主中 SARS-CoV-2 感染的监测和分子特征分析。
Int J Environ Res Public Health. 2022 Nov 3;19(21):14391. doi: 10.3390/ijerph192114391.
4
Sex-Specific Association between Underlying Diseases and the Severity and Mortality Due to COVID-19 Infection: A Retrospective Observational Cohort Analysis of Clinical Epidemiological Information Collected by the Korea Disease Control and Prevention Agency.基础疾病与新型冠状病毒肺炎感染所致严重程度及死亡率之间的性别特异性关联：对韩国疾病控制与预防机构收集的临床流行病学信息进行的回顾性观察队列分析
Healthcare (Basel). 2022 Sep 23;10(10):1846. doi: 10.3390/healthcare10101846.
5
COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.疫苗实施期间的 COVID-19 退出策略：在社交距离和群体免疫之间取得平衡。
Arch Virol. 2022 Sep;167(9):1773-1783. doi: 10.1007/s00705-022-05495-7. Epub 2022 Jun 20.
6
Novel Coronavirus (SARS-CoV-2) in Water and Environment-A Scoping Review.水中和环境中的新型冠状病毒（SARS-CoV-2）——一项概述性综述
Life (Basel). 2022 Mar 31;12(4):520. doi: 10.3390/life12040520.
7
Evaluating COVID-19 control measures in mass gathering events with vaccine inequalities.评估疫苗不平等情况下大型集会活动中的 COVID-19 控制措施。
Sci Rep. 2022 Mar 7;12(1):3652. doi: 10.1038/s41598-022-07609-2.
8
COVID-19 Vaccines: An Overview of Different Platforms.新冠疫苗：不同平台概述
Bioengineering (Basel). 2022 Feb 12;9(2):72. doi: 10.3390/bioengineering9020072.
9
Evaluation of thorax computed tomographic findings in COVID-19 variant cases.评估 COVID-19 变异病例的胸部计算机断层扫描结果。
Respir Investig. 2022 May;60(3):364-368. doi: 10.1016/j.resinv.2021.11.013. Epub 2022 Jan 4.
10
Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines.严重急性呼吸综合征冠状病毒 2 的分子进化：新冠疫情背后的危险和更危险的毒株及其药物和疫苗靶点。
Front Cell Infect Microbiol. 2021 Dec 14;11:763687. doi: 10.3389/fcimb.2021.763687. eCollection 2021.
本文引用的文献
1
Covid-19: Pfizer BioNTech vaccine reduced cases by 94% in Israel, shows peer reviewed study.同行评议研究显示，在以色列，新冠病毒-19：辉瑞生物科技公司的疫苗使病例减少了94%。
BMJ. 2021 Feb 25;372:n567. doi: 10.1136/bmj.n567.
2
Covid-19: What have we learnt about the new variant in the UK?新冠疫情：我们对英国的新变种病毒了解多少？
BMJ. 2020 Dec 23;371:m4944. doi: 10.1136/bmj.m4944.
Zotero 插件